Insider · CIK 0001744046

Karp Daniel

Reports to the SEC for 2 companies · JERSEY CITY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001744046

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-31	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+11.3K sh	—	—	68,491.923
2026-03-31	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−3,554 sh	$5.70	−$20.3K	64,937.923
2026-03-31	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+6,715 sh	—	—	71,652.923
2026-03-31	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−2,105 sh	$5.70	−$12K	69,547.923
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Executive VP, Corp. Dev.	AAward	+100K sh	—	—	100,166
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−11.3K sh	—	—	0
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−6,715 sh	—	—	13,432
2026-03-29	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+14.2K sh	—	—	60,853.46
2026-03-29	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−4,446 sh	$5.84	−$26K	57,153.923
2026-03-29	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−14.2K sh	—	—	14,185
2025-05-06	OGNOrganon & Co.P Purchase	Executive VP, Corp. Dev.	PPurchase	+3,500 sh	$8.24	+$28.8K	46,669.46
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+14.2K sh	—	—	33,546.46
2025-03-31	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−4,446 sh	$14.51	−$64.5K	29,100.46
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+11.3K sh	—	—	40,438.46
2025-03-31	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−3,554 sh	$14.51	−$51.6K	36,884.46
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+4,861 sh	—	—	41,745.46
2025-03-31	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−1,524 sh	$14.51	−$22.1K	40,221.46
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	+4,294 sh	—	—	44,515.46
2025-03-31	OGNOrganon & Co.F Tax Payment	Executive VP, Corp. Dev.	FTax Payment	−1,346 sh	$14.51	−$19.5K	43,169.46
2025-03-31	OGNOrganon & Co. · Stock Option (right to buy)A Award	Executive VP, Corp. Dev.	AAward	+99K sh	—	—	99,009
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Executive VP, Corp. Dev.	AAward	+20.1K sh	—	—	20,147
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−14.2K sh	—	—	28,369
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−11.3K sh	—	—	11,338
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−4,861 sh	—	—	0
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Executive VP, Corp. Dev.	MExercise/Conversion	−4,294 sh	—	—	0
2020-02-12	BIIBBIOGEN INC.M Exercise/Conversion	EVP, Corporate Development	MExercise/Conversion	+960 sh	—	—	1,224.387
2020-02-12	BIIBBIOGEN INC.F Tax Payment	EVP, Corporate Development	FTax Payment	−294 sh	$331.76	−$97.5K	930.387
2020-02-12	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Corporate Development	MExercise/Conversion	−960 sh	—	—	5,300
2020-02-12	BIIBBIOGEN INC. · Restricted Stock UnitJ Other	EVP, Corporate Development	JOther	−1,126 sh	—	—	4,174
2020-02-12	BIIBBIOGEN INC. · Restricted Stock UnitA Award	EVP, Corporate Development	AAward	+6,030 sh	—	—	6,030
2019-07-02	BIIBBIOGEN INC.M Exercise/Conversion	EVP, Corporate Development	MExercise/Conversion	+196 sh	—	—	322.387
2019-07-02	BIIBBIOGEN INC.F Tax Payment	EVP, Corporate Development	FTax Payment	−58 sh	$236.37	−$13.7K	264.387
2019-07-02	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	EVP, Corporate Development	MExercise/Conversion	−196 sh	—	—	1,564
2019-07-02	BIIBBIOGEN INC. · Restricted Stock UnitJ Other	EVP, Corporate Development	JOther	−390 sh	—	—	1,174
2019-02-12	BIIBBIOGEN INC. · Restricted Stock UnitA Award	EVP, Corporate Development	AAward	+6,260 sh	—	—	6,260
2018-07-02	BIIBBIOGEN INC. · Restricted Stock UnitA Award	EVP, Corporate Development	AAward	+1,760 sh	—	—	1,760

Recent filings

Accepted (ET)
Apr 24
Karp Daniel0001628280-26-023180
SEC(opens sec.gov)
Mar 314
Karp Daniel0001628280-26-022415
SEC(opens sec.gov)
May 74
Karp Daniel0001821825-25-000029
SEC(opens sec.gov)
Apr 24
Karp Daniel0001821825-25-000018
SEC(opens sec.gov)

Companies

Address

C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33

JERSEY CITY, NJ, 07032